52108 Federal Register / Vol. 70, No. 169 / Thursday, September 1, 2005 / Notices 

have a significant economic impact on 

a substantial number of small entities. 

Therefore, we are not preparing an 

analysis for the RFA. 

In addition, section 1102(b) of the 

Social Security Act (the Act) requires us 

to prepare a regulatory impact analysis 

if a rule may have a significant impact 

on the operations of a substantial 

number of small rural hospitals. This 

analysis must conform to the provisions 

of section 604 of the RFA. For purposes 

of section 1102(b) of the Act, we define 

a small rural hospital as a hospital that 

is located outside of a Metropolitan 

Statistical Area and has fewer than 100 

beds. We have determined that this 

notice will not have a significant effect 

on the operations of a substantial 

number of small rural hospitals. 

Therefore, we are not preparing an 

analysis for section 1102(b) of the Act. 

Section 202 of the Unfunded 

Mandates Reform Act of 1995 also 

requires that agencies assess anticipated 

costs and benefits before issuing any 

rule that may result in expenditures in 

any 1 year by State, local, or tribal 

governments, in the aggregate, or by the 

private sector, of $110 million. This 

notice has no consequential effect on 

State, local, or tribal governments or on 

the private sector. 

Executive Order 13132 establishes 

certain requirements that an agency 

must meet when it publishes a rule that 

imposes substantial direct requirement 

costs on State and local governments, 

preempts State law, or otherwise has 

Federalism implications. This notice 

will not have a substantial effect on 

State or local governments. There are no 

other alternatives at this time. 

In accordance with the provisions of 

Executive Order 12866, this notice was 

reviewed by the Office of Management 

and Budget. 

Authority: Sections 1102 and 1871 of the 

Social Security Act (42 U.S.C. 1302 and 

1395hh). 

(Catalog of Federal Domestic Assistance 

Program No. 93.774, Medicare—

Supplementary Medical Insurance Program) 

Dated: May 17, 2005. 

Mark B. McClellan, 

Administrator, Centers for Medicare & 

Medicaid Services. 

Approved: August 25, 2005. 

Michael O. Leavitt, 

Secretary. 

[FR Doc. 05–17278 Filed 8–26–05; 9:46 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Family and Youth Services Bureau; 

Positive Youth Development State and 

Local Collaboration Demonstration 

Projects 

AGENCY: Family and Youth Services 

Bureau, Administration for Children 

and Families (ACF), Department of 

Health and Human Services (HHS). 

ACTION: Award announcement. 

CFDA#: The Catalog of Federal 

Domestic Assistance (CFDA) number for 

this program is 93.623. The title is the 

Positive Youth Development State and 

Local Collaboration Demonstration 

Projects. 

Legislative Authority: Grants for 

Runaway and Homeless Youth programs 

are authorized by the Runaway and 

Homeless Youth Act (title III of the 

Juvenile Justice and Delinquency 

Prevention Act of 1974), as amended by 

the Missing, Exploited, and Runaway 

Children Protection Act of 1999, (Pub. 

L. 106–71). 

Amount of Award: $100,000 per 

grantee. 

Project Period: 9/30/04–9/29/05. 

SUMMARY: Notice is hereby given that a 

noncompetitive grant supplement is 

being made to the following state 

agencies: State of Nebraska Health & 

Human Services, University of 

Kentucky Research Foundation, State of 

Oregon, New York Office of Children & 

Family Services, State of Louisiana, 

Iowa Dept. of Human Rights Criminal & 

Juvenile Justice, Commonwealth of 

Massachusetts, Illinois Department of 

Human Services, Governor’s Office for 

Children Youth & Families. The purpose 

of this supplement is to support 

collaborations between state-level 

agencies and local community 

jurisdictions regarding positive 

development opportunities available to 

young people as approved in their 

original planning grant. 

FOR FURTHER INFORMATION CONTACT: 

Administration for Children and 

Families, Family and Youth Services 

Bureau, 330 C Street, SW., Washington, 

DC 20447, Courtney Workman—(202) 

205–8657, cworkman@acf.hhs.gov. 

Dated: August 22, 2005. 

Joan E. Ohl, 

Commissioner, Administration on Children, 

Youth and Families. 

[FR Doc. 05–17371 Filed 8–31–05; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2005N–0343] 

Agency Emergency Processing Under 

Office of Management and Budget 

Review; Guidance for Requesting an 

Extension to Use Existing Label Stock 

After the Trans Fat Labeling Effective 

Date of January 1, 2006 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for emergency processing under 

the Paperwork Reduction Act of 1995 

(the PRA). FDA is preparing a guidance 

document to notify the public of 

procedures being implemented by the 

agency to assist firms that wish to 

request, on a case-by-case basis upon an 

appropriate showing, an extension to 

use existing label stock after the 

effective date of the trans fat labeling 

final rule. This notice solicits comments 

on the proposed collection of 

information associated with the 

guidance document entitled ‘‘Guidance 

for Requesting an Extension to Use 

Existing Label Stock After the Trans Fat 

Labeling Effective Date of January 1, 

2006.’’

DATES: Fax written comments on the 

collection of information by October 3, 

2005. FDA is requesting approval of this 

emergency processing by September 8, 

2005. 

ADDRESSES: OMB is still experiencing 

significant delays in the regular mail, 

including first class and express mail, 

and messenger deliveries are not being 

accepted. To ensure that comments on 

the information collection are received, 

OMB recommends that comments be 

faxed to the Office of Information and 

Regulatory Affairs, OMB, Attn: Fumie 

Yokota, Desk Officer for FDA, FAX: 

202–395–6974. 

FOR FURTHER INFORMATION CONTACT: 

Peggy Robbins, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1223. 

SUPPLEMENTARY INFORMATION: FDA has 

requested emergency processing of this 

proposed collection of information 

under section 3507(j) of the PRA (44 

U.S.C. 3507(j)) and 5 CFR 1320.13. FDA 

issued a final rule (the trans fat final 

rule) on July 11, 2003 (68 FR 41434) to